Amgen, the maker of evolocumab (Repatha) funded the research, paid EVERY author on the paper, led by Harvard researchers, and the findings were published in the prestigious New England Journal of Medicine May 4, 2017. If you take the drug, evolocumab (Repatha), your LDL will go down but you won’t live any longer. IT’S ALL ABOUT INFLAMMATION AND OXIDATION.
High lipoprotein(a), Lp(a), found in 20% of people’s blood is a risk factor for coronary heart disease (CHD), cardiovascular disease (CVD) including aortic stenosis, atherosclerosis, thrombosis, stroke, cancer, and diabetes mellitus.
“research” that was bought from a famous institution, Harvard, published in a famous medical journal, New England Journal of Medicine, was not questioned and negatively influenced the medical profession and public for decades, costing incalculable number of lives and dollars.
Our Ten Point Plan reviews lifestyle factors you need to modify to decrease your risk of cancer and heart disease. And now with this new information about telomeres, the very same Simone Ten Point Plan can help you slow the progression of aging.
All cinnamon doses reduced the fasting serum glucose (18–29%), triglyceride (23–30%), LDL cholesterol (7–27%), and total cholesterol (13–26%) levels. WARNING: COUMARIN IS FOUND IN CINNAMON
If you stop the statin, like Lipitor, Crestor, and Zocor, the problems usually go away.
Foods that increase blood sugar will also increase small LDL particles within two hours. Small LDL particles are oxidized and are glycalated – form complexes with glucose that lead to inflammation and oxidation increasing the risk for cardiovascular disease, cancer, and other chronic illnesses.
INFLAMMATION AND OXIDATION DECREASE ATHLETIC PERFORMANCE AND INCREASE THE RISK FOR CANCER, CARDIOVASCULAR DISEASE, DIABETES, DEMENTIA, AND MANY OTHER CHRONIC DISEASES AS WELL AS SHORTENED LIFESPANS